Last updated: 11 March 2022 at 4:09pm EST

Robert Lisicki Net Worth




The estimated Net Worth of Robert Lisicki is at least $7.08 Million dollars as of 3 August 2021. Mr. Lisicki owns over 17,500 units of Arena Pharmaceuticals Inc stock worth over $3,359,764 and over the last 5 years he sold ARNA stock worth over $458,765. In addition, he makes $3,260,860 as Executive Vice President and Chief Commercial Officer at Arena Pharmaceuticals Inc.

Mr. Lisicki ARNA stock SEC Form 4 insiders trading

Robert has made over 8 trades of the Arena Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 17,500 units of ARNA stock worth $716,625 on 3 August 2021.

The largest trade he's ever made was exercising 30,000 units of Arena Pharmaceuticals Inc stock on 4 August 2020 worth over $1,228,500. On average, Robert trades about 8,208 units every 55 days since 2019. As of 3 August 2021 he still owns at least 33,601 units of Arena Pharmaceuticals Inc stock.

You can see the complete history of Mr. Lisicki stock trades at the bottom of the page.





Robert Lisicki biography

Robert Lisicki serves as Executive Vice President and Chief Commercial Officer of the Company. Mr. Lisicki brings over 20 years of experience in biopharmaceutical management, sales and marketing to Arena. Mr. Lisicki most recently served as General Manager, Vice President Cardio-Metabolic and Inflammation at Regeneron Pharmaceuticals, Inc. Prior to joining Regeneron, he was Senior Vice President of Sales and Marketing and Chief Customer Officer at Daiichi Sankyo, Inc. Prior to Daiichi Sankyo, Mr. Lisicki held several management positions at Amgen Inc., including Vice President and General Manager, responsible for a 700+ person sales force in the U.S. His U.S. leadership experiences included such market shaping products Enbrel and Prolia. During his tenure he also covered several ex-U.S. regions, and worked as an International Franchise Lead running the development and international strategies and business plans across Amgen's portfolio including Nephrology, Cardiology, Bone and Oncology. Prior to joining Amgen, Mr. Lisicki held various sales and marketing positions at Johnson & Johnson Corporation. Mr. Lisicki holds a Bachelor of Science degree in Finance and Business Administration from the State University of New York at Albany.

What is the salary of Robert Lisicki?

As the Executive Vice President and Chief Commercial Officer of Arena Pharmaceuticals Inc, the total compensation of Robert Lisicki at Arena Pharmaceuticals Inc is $3,260,860. There are 2 executives at Arena Pharmaceuticals Inc getting paid more, with Amit Munshi having the highest compensation of $8,931,400.



How old is Robert Lisicki?

Robert Lisicki is 53, he's been the Executive Vice President and Chief Commercial Officer of Arena Pharmaceuticals Inc since 2018. There are 7 older and 5 younger executives at Arena Pharmaceuticals Inc. The oldest executive at Arena Pharmaceuticals Inc is Garry Neil, 67, who is the Independent Director.

What's Robert Lisicki's mailing address?

Robert's mailing address filed with the SEC is C/O ARENA PHARMACEUTICALS, INC., 6154 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121.

Insiders trading at Arena Pharmaceuticals Inc

Over the last 21 years, insiders at Arena Pharmaceuticals Inc have traded over $9,243,184 worth of Arena Pharmaceuticals Inc stock and bought 78,040 units worth $252,505 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Manmeet Singh Soni, and Garry Arthur Neil. On average, Arena Pharmaceuticals Inc executives and independent directors trade stock every 39 days with the average trade being worth of $3,133,387. The most recent stock trade was executed by Amit Munshi on 16 August 2021, trading 1,000 units of ARNA stock currently worth $48,190.



What does Arena Pharmaceuticals Inc do?

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas



What does Arena Pharmaceuticals Inc's logo look like?

Arena Pharmaceuticals Inc logo

Complete history of Mr. Lisicki stock trades at Arena Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
3 Aug 2021 Robert Lisicki
EVP and Chief Commercial Officer
Option 17,500 $40.95 $716,625
3 Aug 2021
33,601
2 Feb 2021 Robert Lisicki
EVP and Chief Commercial Officer
Option 17,500 $40.95 $716,625
2 Feb 2021
26,941
7 Jan 2021 Robert Lisicki
EVP and Chief Commercial Officer
Option 12,600 $77.59 $977,634
7 Jan 2021
12,600
1 Dec 2020 Robert Lisicki
EVP and Chief Commercial Officer
Sale 3,872 $66.06 $255,784
1 Dec 2020
0
25 Nov 2020 Robert Lisicki
EVP and Chief Commercial Officer
Option 6,300 $65.50 $412,650
25 Nov 2020
6,300
4 Aug 2020 Robert Lisicki
EVP and Chief Commercial Officer
Option 30,000 $40.95 $1,228,500
4 Aug 2020
30,000
13 Nov 2019 Robert Lisicki
EVP and Chief Commercial Officer
Sale 4,429 $45.83 $202,981
13 Nov 2019
0
14 Oct 2019 Robert Lisicki
EVP and Chief Commercial Officer
Option 6,300 $47.32 $298,116
14 Oct 2019
6,300


Arena Pharmaceuticals Inc executives and stock owners

Arena Pharmaceuticals Inc executives and other stock owners filed with the SEC include: